DELRAY BEACH, Fla. — A high-speed passenger train collided with a fire truck at a crossing Saturday morning in Florida, injuring three firefighters and at least a dozen train passengers, authorities said. The crash happened at 10:45 a.m. in crowded downtown Delray Beach, multiple news outlets reported. The Brightline train was stopped on the tracks, its front destroyed, about a block away from the Delray Beach Fire Rescue truck, its ladder ripped off and strewn in the grass several yards away, The Sun-Sentinel reported. The Delray Beach Fire Rescue said in a social media post that three Delray Beach firefighters were in stable condition at a hospital. Palm Beach County Fire Rescue took 12 people from the train to the hospital with minor injuries. Emmanuel Amaral rushed to the scene on his golf cart after hearing a loud crash and screeching train brakes from where he was having breakfast a couple of blocks away. He saw firefighters climbing out of the window of their damaged truck and pulling injured colleagues away from the tracks. One of their helmets came to rest several hundred feet away from the crash. “The front of that train is completely smashed, and there was even some of the parts to the fire truck stuck in the front of the train, but it split the car right in half. It split the fire truck right in half, and the debris was everywhere,” Amaral said. Brightline officials did not immediately comment on the crash. A spokesperson for the National Transportation Safety Board said it was still gathering information about the crash and had not decided yet whether it will investigate. The NTSB is already investigating two crashes involving Brightline’s high-speed trains that killed three people early this year at the same crossing along the railroad’s route between Miami and Orlando. More than 100 people have died after being hit by trains since Brightline began operations in July 2017 — giving the railroad the worst death rate in the nation. But most of those deaths have been either suicides, pedestrians who tried to run across the tracks ahead of a train or drivers who went around crossing gates instead of waiting for a train to pass. Brightline has not been found to be at fault in those previous deaths. Railroad safety has been a concern since a Norfolk Southern train derailed in East Palestine, Ohio, in February 2023, spilling toxic chemicals that caught fire. Regulators urged the industry to improve safety and members of Congress proposed a package of reforms, but railroads have not made many major changes to their operations and the bill has stalled. Earlier this month the two operators of a Union Pacific train were killed after it collided with a semitrailer truck that was blocking a crossing in the small West Texas town of Pecos. Three other people were injured, and the local Chamber of Commerce building was damaged. ———Trump cabinet picks including Matt Gaetz targeted by bomb threats and swatting
Northern Ireland Ambulance Service (NIAS) stock image. Picture: Aodhan Roberts/Belfast Telegraph Northern Ireland Ambulance Service (NIAS) stock image. Picture: Aodhan Roberts/Belfast Telegraph There were over 100 people across Northern Ireland left waiting for ambulances on Friday night, with Saturday evening also displaying similar pressures throughout the health system. The Northern Ireland Ambulance Service (NIAS) made the decision to only respond to serious ‘life or death’ situations. A spokesperson said that the service is “experiencing severe challenges as a result of the pressures being felt across the HSC (health and social) system today.” “Emergency Crews on duty today and tonight will be supplemented by Rapid Response paramedics and further support has been provided by the Independent and Voluntary ambulance sectors. "These crews will deal with lower acuity calls, thereby keeping NIAS crews available for more serious emergencies. “Delayed turnarounds at hospitals impact on NIAS capacity to respond to life threatening emergencies in the community and we continue to work closely with EDs to release crews at the earliest opportunity. The spokesperson continued: “All calls received by NIAS are subject to triage to ensure that those who are sickest, receive our quickest response. This will unfortunately mean delays for patients waiting with less urgent conditions and NIAS would apologise to those patients who find themselves in this situation. “We would ask the public to consider other alternatives to calling 999, such as seeking advice from GP out-of- hours, advice from pharmacist, or self presentation at hospitals if absolutely necessary. “We would also ask those who are waiting for an ambulance, not to call back as this can impact on the ability of our control room staff to promptly answer calls, more serious in nature. “NIAS also has a number of Paramedics in the control room who may call patients back to establish the most appropriate action to meet their needs, which may include non attendance at hospital. “We appreciate and ask for continued patience of the public as they wait for an ambulance response. We are doing what we can to improve the situation.” The announcement follows news that nearly 400 people are waiting on hospital beds throughout the region as well this weekend. BBC News NI reported that “one ambulance has been waiting outside a hospital for nine hours on Saturday, and that there is not enough staff or space to facilitate crews or patients. The Western Trust said that as of Saturday afternoon, 70 people are awaiting beds across their trust area. On Friday, the Belfast Health and Social Care Trust reported a total of 38 patients were waiting for admission to a hospital bed. "When fewer people are in work, the numbers we see in emergency departments are exacerbated as they are more likely to come in for lesser injuries, which shows these increases in waiting periods,” said a spokesperson for the Belfast Trust.
Skobalj's 19 help UIC down La Salle 96-83
TikTok is inching closer to a potential ban in the US. So what’s next?
US to require passenger vehicles to sound alarms if rear passengers don't fasten their seat belts
Thierry Henry gives verdict on Liverpool and Mohamed Salah's contract disputeNo. 22 Xavier unbeaten but looking for more effort vs. South Carolina
NFL coaches could be in for a Black Monday bloodbath with ‘7 to 10’ openings: insider
China eyes negotiations as Trump threatens new tariffs
Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today reported financial results for the second quarter fiscal 2025 ended October 31, 2024 and provided a business update. Second Fiscal Quarter 2025 Highlights: In the run up to the close of 2024 and the second quarter of fiscal year 2025 ("Q2 FY2025”), HeartSciences saw across the board material progress and more positive developments for the field of AI-ECG, its MyoVista® wav ECG TM device, MyoVista® Insights TM cloud-native platform and first cloud-based AI-ECG algorithms. A summary of current status and business highlights during Q2 FY2025 include: "We end calendar 2024 in a strong position, having made significant progress. HeartSciences is the only Company developing across the board ECG solutions to upgrade archaic devices, clinical capabilities, and reporting and management systems which are a necessity for any healthcare system worldwide.” "By calendar year end, our Phase 1 MyoVista Insights cloud-native platform will be complete after millions of dollars of investment. Feedback to date has been excellent and we are in discussions for early deployment in test environments. Our ultimate vision is to offer a path to modernize legacy ECG management systems, as they are generally inflexible and costly due to decades-old IT architecture. Instead, we will provide a next-gen, cybersecure cloud-native system to meet the sophisticated data driven needs of today's health systems. Our AI-ECG marketplace will facilitate far quicker rollout of AI-ECG and allow patients and health systems environments to realize their significant benefits.” "Our MyoVista wav ECG is approaching FDA submission and will allow next-to-patient, immediate access to AI-ECG results which is suitable for many frontline healthcare settings and territories around the world. Our versatility will enable us to deliver AI-ECG solutions across a wide range of healthcare settings, from large hospital systems to simple nurse-led mobile testing services.” concluded Mr. Simpson. Second Quarter Fiscal 2025 Financial Results There were no revenues during Q2 FY2025. As of October 31, 2024, cash and cash equivalents were approximately $4.1 million and shareholders' equity was approximately $4.0 million. Complete financial results have been filed in the Company's Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission and is available on the Company's website. About HeartSciences HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and intends to provide these AI-ECG algorithms on a device agnostic cloud-based solution as well as a low-cost ECG hardware platform. Working with clinical experts, HeartSciences ensures that all solutions are designed to work within existing clinical care pathways, making it easier for clinicians to use AI-ECG technology to improve their patient's care and lead to better outcomes. HeartSciences' first product candidate for FDA clearance, the MyoVista® wavECGTM, or the MyoVista®, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction which has traditionally only been available through the use of cardiac imaging. The MyoVista® also provides conventional ECG information in the same test. For more information, please visit: https://www.heartsciences.com . X: @HeartSciences Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and are relating to the Company's future financial and operating performance. All statements, other than statements of historical facts, included herein are "forward-looking statements" including, among other things, statements about HeartSciences' beliefs and expectations. These statements are based on current expectations, assumptions and uncertainties involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the Company's control. The expectations reflected in these forward-looking statements involve significant assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Potential risks and uncertainties include, but are not limited to, risks discussed in HeartSciences' Annual Report on Form 10-K for the fiscal year ended April 30, 2024, filed with the U.S. Securities and Exchange Commission (the "SEC") on July 29, 2024, HeartSciences' Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2024, filed with the SEC on September 12, 2024, HeartSciences' Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2024, filed with the SEC on December 16, 2024 and in HeartSciences' other filings with the SEC at www.sec.gov . Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements. Contacts: HeartSciences Gene Gephart +1-682-244-2578 Ext. 2024 [email protected] Investors Gilmartin Group Vivian Cervantes [email protected]
PM Modi to inaugurate and launch projects worth over Rs 46,300 crore in Rajasthan todayWorkday shares pop 9% on inclusion in S&P 500Lisa Kudrow was also grossed out by Robert Zemeckis’ Here
Vikings make myriad of roster moves to ensure special teams don't crater amid injury issues
Asia Distillates-Muted activity; refiner spot sales in discountHow Artificial Intelligence of Everything Will Transform Everything?SAU hosts conference on CPEC energy infrastructure
You will bear all civil or criminal legal responsibilities directly or indirectly caused by your actions and speech.
Message board administrators have the right to retain or delete any content in the messages under their jurisdiction.
This site reminds: Do not make personal attacks. Thank you for your cooperation.
mcw casino apps login All rights reserved. Unauthorized reproduction, copying or mirroring is prohibited. Violators will be held accountable.
Statement: All information presented on this site is edited and published by the mcw casino apps login work team. Copyright is reserved. Plagiarism is strictly prohibited. Do not reproduce or mirror without authorization. Otherwise, this site reserves the right to pursue legal liability.
Copyright © 2018 Tencent. All Rights Reserved